C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
01/2003
01/02/2003	EP1109785B1 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
01/02/2003	EP0891341B1 1,3,4-oxadiazine derivatives and their use as pesticides
01/02/2003	EP0804431B9 GLYCOPROTEIN IIb/IIIa ANTAGONISTS
01/02/2003	EP0751939B9 Naphthylamides as central nervous system agents
01/02/2003	EP0630366B1 Substituted heterocyclic derivatives useful as platelet aggregation inhibitors
01/01/2003	CN1388119A Stereoselective preparation for chirality 1-aryl-and 1-heteroaryl-2-substituted-ethyl-2-amine
01/01/2003	CN1097588C Dihydrobenzofuran and related compounds used as anti-inflammatory agents
12/2002
12/31/2002	US6500865 Sulfonamide derivatives
12/31/2002	US6500849 Administering antiinflammatory, antiproliferative, nootropic or antigrowth agents, such as 6-(1-dodecynyl)-2-pyridine-carboxaldehyde and enantiomorphs to mammals; alzheimers disease
12/31/2002	US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome
12/31/2002	US6500803 Factor VIIa inhibitors
12/27/2002	WO2002102389A1 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
12/27/2002	WO2002082185B1 Perfluoroalkylsulfonic acid compounds for photoresists
12/27/2002	WO2001023352A9 Preparation of sulfonyl imine compounds
12/26/2002	US20020198383 For use in regioselective and enantioselective alkylations of allylic substrates
12/26/2002	US20020198376 As therapeutic agents for autoimmune diseases such as rheumatoid arthritis
12/26/2002	US20020198236 Small organic molecule regulators of cell proliferation
12/26/2002	US20020198235 Use of benzothiopenes to treat and prevent prostate cancer
12/26/2002	US20020198207 Novel Hexanoic acid derivatives
12/26/2002	US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
12/26/2002	US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
12/26/2002	US20020197558 Photoacid generators for use in photoresist compositions
12/25/2002	CN1387518A Heterocyclic substd, diphenyl leukotriene antagonists
12/25/2002	CN1387507A Diaryl-enynes
12/25/2002	CN1097052C Process for production of amidinoindole derivs, and salts thereof
12/25/2002	CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides
12/24/2002	US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same
12/24/2002	US6498187 Fatty acid synthase inhibitors
12/24/2002	US6498185 Enzyme factor xa inhibitors
12/24/2002	US6498172 Prostaglandin agonists and their use to treat bone disorders
12/24/2002	CA2150812C Catechol diethers as selective pde iv inhibitors
12/19/2002	WO2002100851A2 Thiophene derivatives as antiviral agents for flavivirus infection
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002	WO2002100830A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	WO2002100825A2 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances
12/19/2002	WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/19/2002	WO2002100819A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same
12/19/2002	WO2002100813A2 Modulators of peroxisome proliferator activated receptors
12/19/2002	WO2002100802A2 Fluorous triphase and other multiphase systems
12/19/2002	WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	WO2002100388A2 Cyclopentane heptan (ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
12/19/2002	WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/19/2002	WO2002100341A2 Compounds for the treatment of metabolic disorders
12/19/2002	US20020193614 Treatment of cardiovascular disorders
12/19/2002	US20020193596 Inhibitors of protein isoprenyl transferases
12/19/2002	US20020193578 Compounds having activity as inhibitors of cytochrome P450RAI
12/19/2002	US20020193383 1-(N-phenylalkylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
12/19/2002	US20020189033 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same
12/19/2002	DE10128331A1 New 2-(heteroarylsulfonyl-amino)-benzamide derivatives, which are potassium ion channel blocking antiarrhythmic agents, useful for e.g. treating atrial fibrillation or flutter
12/19/2002	CA2450220A1 Cyclopentane heptan (ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension
12/19/2002	CA2449629A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	CA2449256A1 Modulators of peroxisome proliferator activated receptors
12/19/2002	CA2448764A1 N-arylphenylacetamide derivatives and pharmaceutical compositions containing the same
12/19/2002	CA2448552A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/18/2002	EP1266898A1 Processes for the production of thienopyrimidine derivatives
12/18/2002	EP1265891A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/18/2002	EP1265865A2 Difluorobutyric acid derivatives and their use as metalloprotease inhibitors
12/18/2002	EP1265857A1 Sulfonamide derivatives
12/18/2002	EP1265855A1 Novel cd23 inhibitors
12/18/2002	EP0934300B1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/18/2002	CN1386124A Method of preparing a polymer, method of preparing a compound, compounds, polymers, and method for manufacturing and electronic device
12/18/2002	CN1096446C N-(ortho-substd-benzyloxy)imine derivs, and their use as fungicides, acaricides or insecticides
12/17/2002	US6495702 Process for preparing 5-hydroxybenzo [b] thiophene-3-carboxylic acid derivatives
12/17/2002	US6495699 Antiarthritic agents; osteoporosis
12/17/2002	US6495691 Their pharmaceutically acceptable salts, wherein the meaning of x is hydrogen, carboxyl, alkoxycarbonyl, aryloxycarbonyl, nitrile, or carbamoyl of the formula ticlopidine, is an antithrombotic drug with platelet aggregation inhibiting
12/17/2002	US6495683 Herpes virus
12/17/2002	US6495607 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
12/17/2002	US6495557 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action
12/17/2002	US6495554 Phosphodiesterase v inhibitors, treating cardiovascular disorders, and therapy of erectile dysfunction.
12/17/2002	US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid.
12/17/2002	CA2064783C Cytoprotective fatty moiety compounds
12/12/2002	WO2002098901A2 Peptide deformylase inhibitors
12/12/2002	WO2002098870A1 Substituted oxime derivatives and the use thereof as latent acids
12/12/2002	WO2002098851A1 Derivatives 0f n,s-substitutions n'-1 [(hetero)aryl] alkyl-n'-[hetero) aryl] methyl isothioureas, method for producing salts and bases thereof, physiologically active n,s-substitutions n'-1 [(hetero)aryl] alkyl-n'-[hetero) aryl] methyl isothioureas, a pharmaceutical composition and curing method
12/12/2002	WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	WO2002098849A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
12/12/2002	WO2002098848A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
12/12/2002	WO2002098840A1 Carboxylic acid derivative and medicine comprising salt or ester of the same
12/12/2002	WO2002098420A1 4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/12/2002	WO2002057252A3 Heterocyclic sulfonamide inhibitors of beta amyloid production
12/12/2002	US20020188139 P-thienylbenzylamides as agonists of angiotensin-(1-7) receptors, and methods of their preparartion and use
12/12/2002	US20020188136 Pesticides and herbicides
12/12/2002	US20020188120 Such as 4-(4-methyoxy-benzenesulfonyl)-1-(3-phenyl-propyl)-piperidine-4-carboxylic acid hydroxyamide for treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone diseases, diabetes, and HIV
12/12/2002	US20020188043 Photochromic diarylethene substituted with isoxazole group
12/12/2002	US20020188017 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments
12/12/2002	US20020187982 Glucagon antagonists/inverse agonists
12/12/2002	US20020187961 Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
12/12/2002	DE10205367A1 Verbindung mit Phenylacetylenstruktur, Flüssigkristallzusammensetzung, Polymer, optisch anisotropes Produkt, optisches oder Flüssigkristall-Element, Dibenzothiophenverbindung, Zwischenprodukt und Verfahren zum Herstellen derselben Compound with Phenylacetylenstruktur, liquid crystal composition, Polymer, optically anisotropic product, or the liquid crystal optical element, Dibenzothiophenverbindung, intermediate and process for producing same
12/12/2002	CA2448834A1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
12/12/2002	CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	CA2446719A1 Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
12/11/2002	EP1264820A1 Novel amide compounds
12/11/2002	EP1263763A2 Tubulin binding ligands and corresponding prodrug constructs
12/11/2002	EP1263743A1 Heterocycle substituted diphenyl leukotriene antagonists
12/11/2002	EP1263714A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263711A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP0937064B1 Substituted oximes derivatives useful as neurokinin antagonists
12/11/2002	EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors

1 ... 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 ... 329